Clinical trials
Liver Transplant clinical trials
Below are recruiting liver transplant clinical trials, each written for real people, not researchers. We’re tracking 194 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07301853Recruiting
Long-term follow-up for liver transplant patients and living donors
This study follows liver transplant recipients and living donors over time to track their health outcomes. It aims to understand their recovery and long-term wellbeing.
Hangzhou, ZhejiangAges 18 years+ - NCT07291258Recruiting
Long-term health study of children born to transplant mothers
This study follows children born to mothers who had a solid organ transplant (like kidney, liver, or heart) to learn about their long-term health. It may help doctors understand how to better care for these families.
Groningen, Provincie GroningenAges Any age - NCT07273448Enrolling by invitation
ABO-mismatched living donor liver transplant study
This study looks at the results of liver transplants from living donors with a different blood type than the recipient. It aims to understand how well patients do after this type of transplant.
Ages Any age - NCT07269041RecruitingPhase 1/Phase 2
Immune tolerance after liver transplant
This trial tests a way to help your body accept your liver transplant without needing lifelong anti-rejection drugs. It uses your living donor's stem cells to train your immune system to not attack the new liver.
Los Angeles, CaliforniaAges 18 years+ - NCT06899867Recruiting
Comparing heart monitoring methods during liver transplant
This trial compares two ways to monitor how well your heart is pumping during liver transplant surgery. One method uses a thin tube in your blood vessels, and the other uses an ultrasound probe placed in your food pipe.
France, LyonAges 18 years+ - NCT07216508Enrolling by invitation
Liver Transplant Blood Sugar Monitoring Study
This study tests whether a continuous glucose monitor (CGM) can help manage blood sugar levels in patients who have just received a liver transplant and have high blood sugar in the hospital.
New York, New YorkAges 18 years+ - NCT06215404Recruiting
Fluid management during liver transplant for less blood loss
This trial tests different ways of managing fluids during liver transplant surgery to see if it can reduce blood loss. It may be helpful for patients with end-stage liver disease who are waiting for a transplant.
TaipeiAges 18–75 - NCT07157631Recruiting
Tranexamic acid for adults having liver transplant
This trial tests if tranexamic acid, a medicine that helps blood clot, can safely reduce bleeding during adult liver transplant surgery.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07053488RecruitingPhase 1/Phase 2
Gene-edited liver transplant to lower rejection risk
This trial tests a liver transplant using a donor organ that has been gene-edited to reduce the risk of rejection. It may help people who need a liver transplant and are not a perfect tissue match with their donor.
Beijing, ChangpingAges 16–85 - NCT06994429Enrolling by invitation
New MRI to check liver function after transplant
This study uses a new MRI technique to check how well your new liver is working after transplant, without any needles or biopsy. If you have had a liver transplant and are scheduled for an MRI, you may be able to join.
Wuhan, HubeiAges 18–80 - NCT06958796RecruitingPhase 4
CMV immunoglobulin to prevent disease after transplant
This trial tests whether giving CMV immunoglobulin (an antibody medicine) after transplant can help prevent a serious CMV infection in people who receive a kidney or liver from a CMV-positive donor. You might be eligible if you are getting one of these transplants and are at high risk for CMV.
Boston, MassachusettsAges 18–75 - NCT06950788Recruiting
Glucose changes in cirrhosis patients around liver transplant
This study looks at how the body processes sugar (glucose) in people with cirrhosis who are waiting for a liver transplant. It aims to track changes in blood sugar control before and after transplant, which may help improve care for patients with liver disease.
Chicago, IllinoisAges 18–75 - NCT05339984Recruiting
MRI-based planning during liver surgery and related procedures
This study uses MRI imaging and computer modeling to better plan liver surgery and related liver treatments. It may help doctors predict circulation (blood flow) changes during surgery and choose safer surgical timing or approaches.
Villejuif, Val de MarneAges 18 years+ - NCT06850753Recruiting
En bloc removal of liver and pancreas with transplant for bile duct cancer
This trial tests a new surgical approach that removes the liver, pancreas, and bile duct all at once (and then gives a liver transplant) for people with a type of bile duct cancer that cannot be removed with standard surgery. It may help people whose cancer is limited to the liver area and who have not responded to other treatments.
OsloAges 18–70 - NCT03789383Recruiting
Living donor liver transplant and biliary complication outcomes study
This study looks at what factors lead to “biliary complications” (problems involving the bile ducts that help move bile from the liver) after an adult living-donor liver transplant. It’s aimed at people who had this specific type of transplant at the study hospital in Egypt.
AsyutAges 18–65 - NCT06774144Enrolling by invitationPhase 3
Rezafungin to prevent fungal infections in liver transplant patients
This trial tests whether a medicine called rezafungin can help prevent serious fungal infections in people who have received a liver transplant. If you have certain risk factors, this study may offer extra protection against infections.
Pittsburgh, PennsylvaniaAges 18 years+ - NCT06749405Recruiting
Using Quantra to Guide Transfusions During Liver Transplant
This study tests a special tool called Quantra, which helps doctors decide when to give blood products during your liver transplant. The goal is to make sure you get just the right amount of transfusions, which could improve your safety and recovery.
ToulouseAges 18 years+ - NCT06130046Recruiting
Study of MR-proADM as a biomarker for kidney and liver transplant
This trial is testing a simple blood biomarker called MR-proADM to see if it can help doctors detect early signs of transplant rejection or poor kidney function after a kidney or liver transplant.
RomeAges 18–70 - NCT06535945RecruitingPhase 4
Albumin to protect kidney function after liver transplant
This trial tests whether giving albumin (a protein in your blood) after a liver transplant can help prevent or reduce kidney damage. It is for adults receiving their first liver-only transplant from a deceased donor.
Chambray-lès-ToursAges 18 years+ - NCT06472973Recruiting
Addiction support after liver transplant
This trial tests a special addiction support program for people who have had a liver transplant because of alcohol-related liver disease. The goal is to help them stay healthy and avoid drinking again.
BesançonAges 18 years+ - NCT06386198Recruiting
Health Advocate for Young Liver Transplant Patients
This study tests a program that helps young adults with a liver transplant prepare to move from a children’s hospital to an adult hospital. It aims to provide extra support for people who also have social needs like trouble getting enough food.
San Francisco, CaliforniaAges 18–25 - NCT05186116Recruiting
Liver transplant for colon cancer that cannot be removed
This trial studies whether liver transplant (rather than removing the liver tumors) can help some people with colon or rectal cancer spread to the liver. It’s meant for people whose cancer has responded or stayed controlled on standard treatments and who have no cancer outside the liver.
Modena, MOAges 18–77 - NCT06257407Recruiting
Managing bleeding during and after liver transplant
This trial studies how doctors manage bleeding before, during, and after liver transplant surgery. The goal is to improve safety and outcomes for people receiving a new liver.
BesançonAges 18 years+ - NCT06169592Recruiting
Bleeding and Clotting Risks After Living Donor Liver Transplant
This study is for people with severe liver cirrhosis who are getting a liver transplant from a living donor. It looks at the risk of bleeding or clotting problems after the transplant, to help doctors better manage these risks.
TashkentAges 18–70
Hear when a new Liver Transplant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for liver transplant?
- Yes. Clin2 currently lists 194 recruiting liver transplant studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a liver transplant trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a liver transplant trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.